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Noncoding RNAs have emerged as important determinants of pluripotency and reprogramming. In this issue
ofCell Stem Cell, Kosik and colleagues now provide a detailedmap of microRNA expression patterns to infer
the biological states of embryonic and induced pluripotent stem cells.What are the molecular determinants of
pluripotency?Thisquestion liesat theheart
of currentdebatesabout theequivalenceof
embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs) (reviewed
by Loh and Lim, 2010). While the develop-
mental potential of mouse iPSCs can be
evaluated by their ability to contribute to
or generate entire embryos, such experi-
ments are not possible for human iPSCs
envisioned for use in regenerativemedicine
applications. Thus, it is necessary to
uncover molecular markers that corre-
spond with the biological properties of
hiPSCs in order to gauge their degree of
pluripotency. Prior studies have examined
genome-wide patterns of chromatin state,
mRNA expression, and on a more limited
level, microRNA (miRNA) expression (Loh
and Lim, 2010). In this issue of Cell Stem
Cell, Neveu et al. (2001) now provide
a new perspective based on detailed anal-
ysisofmiRNAs inESCs, iPSCs, andvarious
differentiated and cancer cells.
The authors measured the expression
of 330 miRNAs using a highly quantitative
real time PCR approach in a diverse
setof 49samples.These samples included
authentic ESCs, differentiated cells,
cancer cells, and iPSCs generated with
several combinations of reprogramming
factors and methods of factor delivery.
Unbiased clustering divided the samples
into four distinct categories: differentiated
cells, cancer cells, and two subsets
of pluripotent cells. Furthermore, the use
of multiple supervised classification
methodsgenerateda so-called ‘‘miRMap’’
whichcouldbe used in a predictive fashion
with additional data sets and revealed that
certain pluripotent cells share an overlap-
ping signature with cancer cells.In order to establish the miRMap, the
authors looked for similarities and differ-
ences in the miRNA expression profiles
between the individual samples. The
main sources of variation in the patterns
of miRNA expression can be visualized as
2Dmapsusingprincipal componentsanal-
ysis (PCA), inwhich each dimension repre-
sents a group of coordinately regulated
miRNAs. Principal components (PCs) are
a mathematical abstraction. In brief, given
a matrix of numbers (e.g., 330 miRNAs 3
49 samples), the first PC is the set of
miRNAs that accounts for most of the vari-
ation among the samples. The second PC
is the next set of miRNAs that account for
mostof the remainingvariation, inamanner
that is independent of the first PC. Addi-
tional PCs account for further variation. In
this way, PCA can mathematically identify
the main sources of variation in a complex
matrix. Neveu et al. nicely show that the
first three PCs appear to have meaningful
biological associations. Using this anal-
ysis, pluripotent cells are clearly separated
from all lineage-committed cells, based on
the pluripotency-related miRNAs that
makeup the secondPC (PC2). Intriguingly,
PC3 divides the human pluripotent cells
into two classes. The first class (class 1)
consists of most hESCs and some virus-
derived iPSCs, while the second (class 2)
contains episome- and protein-derived
iPSCs, some virus-derived iPSCs, and
the H9 hESC. Surprisingly, PC3 also sepa-
rates differentiated cells from cancer cells.
The distinction between the four cate-
gories defined by the PCA was optimized
using supervised learningmethods, which
resulted in themiRMap, a 2Dclassification
system (Neveu et al., 2010). The classifier
that distinguishes class 1 and class 2Cell Stem Cell 7,
STEM 824_823pluripotent cells is driven by the expres-
sion of a dozen of miRNAs, which are
absent in the latter. The authors applied
miRMap to several published microarray
data sets, and found that individual lines
could be prospectively segregated into
the twoclassesof humanpluripotent cells.
Importantly, themiRMap can also be used
to visualize the gene expression trajectory
of cells during directed differentiation or
reprogramming. Differentiation and re-
programming do not proceed by direct
transitions from one pattern, or quadrant
of the miRMap to another, but instead
proceed via a circuitous route through an
intermediate stage that exhibits the class
2 pattern, which is characteristic of cancer
cells and some iPSCs. These findings
raise the intriguing possibility that reprog-
ramming cell fate requires the sequential
interplay of proliferation and cell fate
commitment, which needs further investi-
gation (Singh and Dalton, 2009).
To look more closely at the differences
between the two classes of pluripotent
cells revealedbymiRMap, the authors per-
formed Gene Set Enrichment Analysis on
published microarray data from hESCs
and iPSCs. Not only is the expression of a
significantportionof genes in thep53path-
way dysregulated in class 2 pluripotent
cells, the expression of p53 mRNA is also
lower, suggesting that p53 is important in
controlling states of pluripotency. Indeed,
several means of p53 inactivation, includ-
ing enforced expression of miR-92 and
miR-141 that target p53, shifted themiRNA
profile of the disrupted cells from class 1
to class 2. Despite their capacity to induce
this observed shift, miR-92 and miR-141
are not prominent classifiers within











Figure 1. Noncoding RNA Landmarks Distinguish Most ESCs from
Imperfectly Reprogrammed Pluripotent Cells
Imperfectly reprogrammed cells (indicated by asterisk) inappropriately silence
theDlk1-Dio3 locus, express Xist from the active X chromosome (Xa), and lose
expression of p53-dependent miRNAs despite the expression of other genes
associated with pluripotency.
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Previewstarget sites for other miRNAs,
and so it is likely that alterna-
tive miRNAs or factors regu-
late p53 expression in the
two subtypes of pluripotent
cells. Why persistent differ-
ences in p53 pathway activity
are observed between the
two iPSC classes remains
unclear. Nevertheless, these
experiments suggest an
important link between the
status of the p53 network
and a given miRNA profile
during reprogramming, and
raise the question of what
players in the network are
connected to miRNAs ex-
pressed by hESCs and iPSCs.
These new findings add tothe emerging theme that noncoding RNAs
(ncRNAs) serve as key determinants and
barriers of epigenetic reprogramming
(Figure 1). Many long ncRNAs are involved
in the regulation of chromatin states,
specifically in marking chromosomal
regions in an allele-specific or cell-specific
fashion (Lee, 2009). As such, long ncRNAs
can be important regulators of imprinting,
dosage compensation, and lineage deter-
mination—events that need to be properly
reset to return to an ESC-like epigenetic
state. Indeed, Hochedlinger and
colleagues found that aberrant silencing
of an imprinted locus, including long
ncRNAs and other genes, poses a barrier
for high quality iPSC generation, but re-
expression of the locus rescues iPSCpluri-
potency (Stadtfeld et al., 2010). Likewise,
reprogramming of somatic nuclei by
nuclear transfer into eggs is substantially
improvedbyensuring theproper regulation
of Xist, the long ncRNA that inactivates one650 Cell Stem Cell 7, December 3, 2010 ª20of two X chromosomes in female cells (In-
oue et al., 2010). Now we can add p53
pathway miRNAs as another important
source of variation between iPSCs and
ESCs (Neveu et al., 2010). The large
number of miRNAs that modify p53 func-
tion may reflect the degree to which this
genome guardian pathway is activated
during epigenetic reprogramming—which
is known to limit reprogramming efficiency
and may be selected against (reviewed in
Deng and Xu, 2009). Recent evidence of
lineage memory in iPSCs suggests that
other ncRNAs involved in lineage commit-
ment or positional identity may also need
to be reset to ensure successful reprog-
ramming (Kimetal., 2010;Poloetal., 2010).
ThefindingsofNeveuetal. also illuminate
theongoingdebate regarding theproposed
equivalence of ESCs and iPSCs (Loh and
Lim, 2010). If ncRNAs, and specifically
miRNAs, constitute a large part of the func-
tional difference between ESCs and some10 Elsevier Inc.
STEM 824_823iPSCs, such differences may
be easily missed in studies of
chromatin state or mRNA
profiling. As deep sequencing
technologies continue their
rapid ascent toward greater
coverage and affordability, the
panel biomarkers that define
ESC and iPSC states will likely
grow. As Neveu et al. demon-
strated, such markers may
also provide potential inroads
into uncovering mechanisms
that regulate pluripotency and
reprogramming.
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